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ABSTRACT 
In this paper, we report our research results on 




Tremendous advances in molecular biology, both in 
understanding and developing of high throughput data 
acquisition techniques such as mass spectrometry, provide 
ample support for studying complex biological control 
networks [2, 3].  Even with recent substantial advances in 
data management, genomics, and robotics, the discovery of 
new pharmaceutical agents has not accelerated over the last 
few years.  Although the drug industry may approach a 
saturation point for single targeted drugs, simple drug 
treatments that effectively target a control network still 
hold a great deal of promise[4].  Mathematical simulations 
of these complex networks provide researchers a means of 
linking the biochemistry of a reaction pathway to not only 
the resulting healthy phenotype but also to the 
dysfunctional disease state[5-7].  While still in its early 
years, the principles of Systems Biology could have 
profound effects leading to more hypothesis-driven 




   2. OVERVIEW OF SPHINGOLIPID STUDY 
 
Sphingolipids perform a wide variety of biological 
functions:  formation of specialized structures, 
participation in cell-cell and cell-substratum interactions, 
modulation of the behavior of cellular proteins and 
receptors, and signal transduction both as extracellular 
agonists and intracellular mediators.  They are synthesized 
de novo via a common sphingoid base backbone 
(sphinganine) that is modified to produce ceramides and 
more complex phospho- and glycosphingolipids, some of 
which are covalently attached to proteins[1].  The many 
known functions with complex undetermined 
consequences make sphingolipid pathways an excellent 




3. SYSTEM DEVELOPMENT 
 
The goal of this research is to develop system 
approach for biology discovery. Specifically, we want to 
quantitatively characterize the sphingolipid metabolism 
pathway in order to understand their roles in normal 
physiological processes and investigate possible treatment 
 
options for a variety of diseases including cancer.  As 
shown in Figure 1, first, the latest proposed sphingolipid 
metabolism pathways are carefully examined and evaluated 
to insure adequate experimental design. The focus then 
shifts to developing optimized mass spectrometry 
protocols to obtain accurate measurements of the 
sphingolipid composition of cultured cells at distinct time 
points.  After the data is collected, the experimental results 
are stored in a database and are managed by DBMS. The 
governing system equations are formed, and the parameters 
are identified through a series of regression sequences. 
Then a time-based dynamical simulation is created. The 
simulation offers powerful insight into the mysterious 
nature of the biological pathway and initiates an iterative 
process, in which new hypotheses can be quickly 
formulated and then validated at the bench. Because of the 
size and complexity of this pathway, 3-D visualization 
tools are designed and implemented to enhance 
understanding of the biological process and to reformulate 
hypotheses. 
   
                   
4. IMPLEMENTATION 
 
A six-node network was constructed using actual 
sphingolipid metabolism data obtained using mass 
spectrometry.  All of the data points concerned the 
movement of various sphingolipds that contained a 
sixteen-carbon fatty acid.  Although many other 
sphingolipid concentrations were also included in the 
utilized data set, none had the dimensionality required to 
prepare a larger network.  The image below depicts the 
network configuration taken from a SIMULINK model 
file.  The six species are dihydroceramide, 
dihydroglucosylceramide, dihydrosphingomyelin, 
ceramide, glucosylceramide, and sphingomyelin 
represented respectively as DH, GCDH, SMDH, C, GC, 
and SM. 
 
Each node in the network model presented previously is 
constructed from a single differential equation that 
describes the accumulation of the particular species with 
respect to time.  Each node in the system has a different 
































































figure 1.  An example of the dependence can be seen when 
comparing the Ceramide Node with the GCDH node.  The 
Ceramide node is dependent on the relative amount of DH, 
SM, and GC whereas the GCDH node is dependent only on 
the DH concentration and any mass transfer of the species 
entering and leaving the system.  It should be noted that 
because each of these reactions is modeled as reversible 
there is an intrinsic dependence of the node on itself.  This 
dependence for Ceramide is shown in the figure below.  
Notice the feedback loop, shaded gray on image, branching 
off of output coming out of the integrator. 
The system can be modeled using many chemical reaction 
schemes, which have well developed systems equations 
used in control including simple models such a 
continuously stirred reactor. FF
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where: V   =  reactor volume, iF  = inlet volumetric flow 
rate, F  = outlet volumetric flow rate, AC  = 
concentration of species A in the reactor and exiting the 
reactor, AiC  = concentration of species A in the 
entrance stream, BC  = concentration of species B in the 
reactor and exiting the reactor, BiC  = concentration of 
species B in the entrance stream, rk  = reverse reaction 
rate constan, fk = forward reaction rate constant,a = 
reaction order of species A, ß = reaction order of species 
B 
Although well defined in a CSTR, the mass flux for an 
organic biochemical reactor is rather unclear due to its 
ability to support active transport.  The constants V and Fi, 
which correspond to the effective volume of the cell 
culture reactor and inlet volumetric flow rate, cannot be 
quantified efficiently.  The system is also biologically 
incomplete and greatly under sampled so the mass flux 
parameter in the species accumulation differential 
equations has been represented with a single constant value 
Mx, which can be either positive or negative representing 
net influx or outflow of the species in the system.   
Enzyme concentration and other properties of enzymes has 
long been known to be a major player in biochemical 
reactions so it may seem ludicrous to build a network that 
is built of pure mass action parts.  There is very little hope 
that a pure mass action driven network can complete 
classify a biological network, nevertheless mass action 
models are a starting point that should allow the 
foundation of various computational techniques that can 
be scaled up once more data becomes available.  
 Although the parameters of each species 
accumulation function can be solved independently when 
given enough measurements, the equations are inherently 
dependent on each other as indicated by network diagram 
in the first section. 
Linear Regression, Gauss-Newton Method, 
Marquardt-Levenberg, Randomized Nelder-Mead, Random 
Shooting Method, and Generalized Simulated Annealing 
methods are the ones used for finding system parameters. 




5. CONCLUSIONS AND FUTURE WORK 
 
This system was initially built with a series of nonlinear 
forward flux equations as the mathematical model 
governing each reaction.  Then it expands the biological 
relevance and accuracy of the predictive equations by 
including well-documented factors such as enzyme 
dependence and the reversible nature of reactions.  
Ultimately, the goal is to extend the integrated 
experimental and modeling methodologies illustrated in 
sphingolipid metabolism study to other complex biological 
process studies such as signal transduction or gene 
regulation.  Another feature of our research is that the 3-D 
information representation enables the users to orchestrate 
the simulated pathway in real time.       
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Figure 1 Linear Regression 
 
 
Figure 2 Comparison System Results using 
Marquardt-Levenberg 
 
